Staphylococcus aureus: An old pathogen with new weapons

Clinics in Laboratory Medicine

Volumn 30, Issue 1, 2010, Pages 179-208

  Tang, Yi Wei ^a,b   Stratton, Charles W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

Community associated MRSA; Methicillin resistant S aureus (MRSA); Necrotizing fasciitis; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMMUNOGLOBULIN; LEVOFLOXACIN; MINOCYCLINE; RIFAMPICIN; TETRACYCLINE;

ABSCESS DRAINAGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEART ABSCESS; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NECROTIZING FASCIITIS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEPTIC SHOCK; SKIN ABSCESS; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROGNOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77953328205     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.01.005     Document Type: Review

References (223)

1. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10(3):505-520.
2. Kwok A.Y., Chow A.W. Phylogenetic study of Staphylococcus and Macrococcus species based on partial hsp60 gene sequences. Int J Syst Evol Microbiol 2003, 53(Pt 1):87-92.
3. Hammond R.K., White D.C. Inhibition of carotenoid hydroxylation in Staphylococcus aureus by mixed-function oxidase inhibitors. J Bacteriol 1970, 103(3):607-610.
4. Liu G.Y., Essex A., Buchanan J.T., et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 2005, 202(2):209-215.
5. Lally R.T., Ederer M.N., Woolfrey B.F. Evaluation of mannitol salt agar with oxacillin as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985, 22(4):501-504.
6. Ratner H.B., Stratton C.W. Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol 1985, 21(6):995-996.
7. Miller M.B., Tang Y.W. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009, 22(4):611-633.
8. Tang Y.W., Kilic A., Yang Q., et al. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures. J Clin Microbiol 2007, 45(6):1867-1873.
9. Chambers H.F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997, 10(4):781-791.
10. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000, 44(6):1549-1555.
11. Noto M.J., Kreiswirth B.N., Monk A.B., et al. Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus. J Bacteriol 2008, 190(4):1276-1283.
12. Baba T., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359(9320):1819-1827.
13. Okuma K., Iwakawa K., Turnidge J.D., et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002, 40(11):4289-4294.
14. Francis J.S., Doherty M.C., Lopatin U., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40(1):100-107.
15. Gonzalez B.E., Hulten K.G., Dishop M.K., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005, 41(5):583-590.
16. Ito T., Ma X.X., Takeuchi F., et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004, 48(7):2637-2651.
17. Kilic A., Li H., Stratton C.W., et al. Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee. J Clin Microbiol 2006, 44(12):4436-4440.
18. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290(22):2976-2984.
19. Berg A.A. A case of acute osteomyelitis of the femur, with feneral systemic Staphylococcus aureus infection, teminating in recovery. Ann Surg 1900, 31(3):332-339.
20. Ogston A. Micrococcus poisoning. J Anat 1882, 16(4):526-567.
21. Shinefield H.R., Ruff N.L. Staphylococcal infections: a historical perspective. Infect Dis Clin North Am 2009, 23(1):1-15.
22. Vandenbergh M.F., Verbrugh H.A. Carriage of Staphylococcus aureus: epidemiology and clinical relevance. J Lab Clin Med 1999, 133(6):525-534.
23. Popovich K.J. Staphylococcus aureus: not always right under your nose. Infect Control Hosp Epidemiol 2009, 30(8):727-729.
24. Reighard A., Diekema D., Wibbenmeyer L., et al. Staphylococcus aureus nasal colonization and colonization or infection at other body sites in patients on a burn trauma unit. Infect Control Hosp Epidemiol 2009, 30(8):721-726.
25. Vandenbergh M.F., Yzerman E.P., van Belkum A., et al. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999, 37(10):3133-3140.
26. Wertheim H.F., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5(12):751-762.
27. Bischoff W.E., Wallis M.L., Tucker K.B., et al. Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors. Infect Control Hosp Epidemiol 2004, 25(6):485-491.
28. de Almeida Silva H., Steffen Abdallah V.O., Carneiro C.L., et al. Infection and colonization by Staphylococcus aureus in a high risk nursery of a Brazilian teaching hospital. Braz J Infect Dis 2003, 7(6):381-386.
29. Farley J.E., Stamper P.D., Ross T., et al. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. J Clin Microbiol 2008, 46(2):743-746.
30. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339(8):520-532.
31. Nulens E., Gould I., MacKenzie F., et al. Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases. Eur J Clin Microbiol Infect Dis 2005, 24(2):145-148.
32. Peacock S.J., Justice A., Griffiths D., et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003, 41(12):5718-5725.
33. Sdougkos G., Chini V., Papanastasiou D.A., et al. Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics. Clin Microbiol Infect 2008, 14(11):995-1001.
34. Shopsin B., Mathema B., Martinez J., et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000, 182(1):359-362.
35. Ellis M.W., Hospenthal D.R., Dooley D.P., et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004, 39(7):971-979.
36. Kenner J., O'Connor T., Piantanida N., et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003, 24(6):439-444.
37. Zhang W., Shen X., Zhang H., et al. Molecular epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from Chinese pediatric patients. Eur J Clin Microbiol Infect Dis 2009, 28(7):861-864.
38. Qu F., Cui E., Guo T., et al. Nasal colonization and clonal transmission of methicillin-susceptible Staphylococcus aureus in Chinese military volunteers. J Clin Microbiol 2009, 48(1):64-69.
39. Al-Rawahi G.N., Schreader A.G., Porter S.D., et al. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol 2008, 46(2):477-479.
40. Graham P.L., Lin S.X., Larson E.L. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006, 144(5):318-325.
41. Reed A.C., Stiles F.E. Staphylococcus septicemia. Cal West Med 1927, 26(4):492.
42. Skinner D., Keefer C.S. Significance of bacteremia caused by Staphylococcus aureus. Arch Intern Med 1941, 68:851-875.
43. Hoyt R.E., Bissell F.E. Staphylococcus aureus endocarditis: treatment with penicillin. Cal West Med 1941, 63:226-227.
44. Beigelman P.M., Rantz L.A. The clinical importance of coagulase-positive, penicillin-resistant Staphylococcus aureus. N Engl J Med 1950, 242(10):353-358.
45. Spink W.W., Ferris V. Penicillin-resistant staphylococci: mechanisms involved in the development of resistance. J Clin Invest 1947, 26(3):379-393.
46. Lacey R.W. Genetic basis, epidemiology, and future significance of antibiotic resistance in Staphylococcus aureus: a review. J Clin Pathol 1973, 26(12):899-913.
47. Lacey R.W. Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. Bacteriol Rev 1975, 39(1):1-32.
48. Chabbert Y.A., Roussel A. Taxonomy and epidemiology of R plasmids as molecular species. J Antimicrob Chemother 1977, 3(Suppl C):25-33.
49. Lacey R.W., Richmond M.H. The genetic basis of antibiotic resistance in S. aureus: the importance of gene transfer in the evolution of this organism in the hospital environment. Ann N Y Acad Sci 1974, 236(0):395-412.
50. Jevons M.P. "Celbenin" -resistant staphylococci. Br Med J 1961, 1:124-125.
51. Jevons M.P., Parker M.T. The evolution of new hospital strains of Staphylococcus aureus. J Clin Pathol 1964, 17:243-250.
52. Boyce J.M., White R.L., Spruill E.Y. Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J Infect Dis 1983, 148(4):763.
53. Boyce J.M. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?. JAMA 1998, 279(8):623-624.
54. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 2001, 7(2):178-182.
55. Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol 2003, 4(9):641-654.
56. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279(8):593-598.
57. Gardam M.A. Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature. Can J Infect Dis 2000, 11(4):202-211.
58. Ho K.M., Robinson J.O. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 2009, 37(3):457-463.
59. Benito N., Miro J.M., de Lazzari E., et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009, 150(9):586-594.
60. Moore C.L., Hingwe A., Donabedian S.M., et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. Int J Antimicrob Agents 2009, 34(2):148-155.
61. Tenover F.C., Goering R.V. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009, 64(3):441-446.
62. Jarvis W.R., Martone W.J. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992, 29(Suppl A):19-24.
63. Stone A.M., Tucci V.J., Isenberg H.D., et al. Wound infection: a prospective study of 7519 operations. Am Surg 1976, 42(11):849-852.
64. Richards M.J., Edwards J.R., Culver D.H., et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000, 21(8):510-515.
65. Haley R.W., Hightower A.W., Khabbaz R.F., et al. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med 1982, 97(3):297-308.
66. Thompson R.L., Cabezudo I., Wenzel R.P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982, 97(3):309-317.
67. Albrich W.C., Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infect Dis 2008, 8(5):289-301.
68. Temime L., Opatowski L., Pannet Y., et al. Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci U S A 2009, 106(43):18420-18425.
69. Hsu C.C., Macaluso C.P., Special L., et al. High rate of methicillin resistance of Staphylococcus aureus isolated from hospitalized nursing home patients. Arch Intern Med 1988, 148(3):569-570.
70. Bradley S.F. Methicillin-resistant Staphylococcus aureus in nursing homes. Epidemiology, prevention and management. Drugs Aging 1997, 10(3):185-198.
71. Zetola N., Francis J.S., Nuermberger E.L., et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5(5):275-286.
72. King M.D., Humphrey B.J., Wang Y.F., et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144(5):309-317.
73. Hidron A.I., Low C.E., Honig E.G., et al. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009, 9(6):384-392.
74. Gonzalez B.E., Rueda A.M., Shelburne S.A., et al. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006, 27(10):1051-1056.
75. Skov R.L., Jensen K.S. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009, 73(4):364-370.
76. Iwatsuki K., Yamasaki O., Morizane S., et al. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 2006, 42(3):203-214.
77. Tristan A., Ferry T., Durand G., et al. Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J Hosp Infect 2007, 65(Suppl 2):105-109.
78. Carrillo-Marquez M.A., Hulten K.G., Hammerman W., et al. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J 2009, 28(12):1076-1080.
79. Bocchini C.E., Hulten K.G., Mason E.O., et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117(2):433-440.
80. Kempker R., Difrancesco L., Martin-Gorgojo A., et al. Expanding spectrum of illness due to community-associated methicillin-resistant Staphylococcus aureus: a case report. Cases J 2009, 2:7437.
81. Fraser J.D., Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008, 225:226-243.
82. Lappin E., Ferguson A.J. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009, 9(5):281-290.
83. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352(14):1445-1453.
84. Genestier A.L., Michallet M.C., Prevost G., et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005, 115(11):3117-3127.
85. Yamasaki O., Kaneko J., Morizane S., et al. The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005, 40(3):381-385.
86. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359(9308):753-759.
87. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315(5815):1130-1133.
88. Corey G.R. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis 2009, 48(Suppl 4):S254-S259.
89. Hill P.C., Birch M., Chambers S., et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31(2):97-103.
90. Mylotte J.M., McDermott C., Spooner J.A. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987, 9(5):891-907.
91. Blot S.I., Vandewoude K.H., Hoste E.A., et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162(19):2229-2235.
92. Kaech C., Elzi L., Sendi P., et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006, 12(4):345-352.
93. Swingle E.L. Studies on small colony variants of Staphylococcus aureus. J Bacteriol 1935, 29(5):467-489.
94. Looney W.J. Small-colony variants of Staphylococcus aureus. Br J Biomed Sci 2000, 57(4):317-322.
95. McNamara P.J., Proctor R.A. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents 2000, 14(2):117-122.
96. Agarwal H., Verrall R., Singh S.P., et al. Small colony variant Staphylococcus aureus multiorgan infection. Pediatr Infect Dis J 2007, 26(3):269-271.
97. Proctor R.A., von Eiff C., Kahl B.C., et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006, 4(4):295-305.
98. von Eiff C., Peters G., Becker K. The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 2006, 37(Suppl 2):S26-S33.
99. Proctor R.A., Kahl B., von Eiff C., et al. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998, 27(Suppl 1):S68-S74.
100. Kipp F., Becker K., Peters G., et al. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J Clin Microbiol 2004, 42(3):1277-1279.
101. Besier S., Ludwig A., Ohlsen K., et al. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol 2007, 297(4):217-225.
102. Chatterjee I., Kriegeskorte A., Fischer A., et al. In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J Bacteriol 2008, 190(3):834-842.
103. Spearman P., Lakey D., Jotte S., et al. Sternoclavicular joint septic arthritis with small-colony variant Staphylococcus aureus. Diagn Microbiol Infect Dis 1996, 26(1):13-15.
104. Sendi P., Rohrbach M., Graber P., et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006, 43(8):961-967.
105. Neut D., van der Mei H.C., Bulstra S.K., et al. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007, 78(3):299-308.
106. Vaudaux P., Kelley W.L., Lew D.P. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis 2006, 43(8):968-970.
107. Spanu T., Romano L., D'Inzeo T., et al. Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin Infect Dis 2005, 41(5):e48-e52.
108. Seifert H., Wisplinghoff H., Schnabel P., et al. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg Infect Dis 2003, 9(10):1316-1318.
109. Kahl B., Herrmann M., Everding A.S., et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998, 177(4):1023-1029.
110. Agarwal A., Singh K.P., Jain A. Medical significance and management of staphylococcal biofilm. FEMS Immunol Med Microbiol 2009, 19:19.
111. Anderson K.L., Roberts C., Disz T., et al. Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 2006, 188(19):6739-6756.
112. Costerton J.W. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001, 9(2):50-52.
113. Sheagren J.N. Staphylococcal infections of the skin and skin structures. Cutis 1985, 36(5A):2-6.
114. Lemonick DM.Non-tropical pyomyositis caused by methicillin-resistant Staphylococcus aureus: an unusual cause of bilateral leg pain. J Emerg Med 2009. [Epub ahead of print].
115. Dryden M.S. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34(Suppl 1):S2-S7.
116. Lopez F.A., Lartchenko S. Skin and soft tissue infections. Infect Dis Clin North Am 2006, 20(4):759-772. v-vi.
117. Haridas M., Malangoni M.A. Predictive factors for surgical site infection in general surgery. Surgery 2008, 144(4):496-501. [discussion: 501-3].
118. Pessaux P., Atallah D., Lermite E., et al. Risk factors for prediction of surgical site infections in " clean surgery" Am J Infect Control 2005, 33(5):292-298.
119. Suchard J.R. "Spider bite" lesions are usually diagnosed as skin and soft-tissue infections. J Emerg Med 2009, [Epub ahead of print].
120. Smolin G., Hall J.M., Okumoto M., et al. Effect of systemic corticosteroids on antibody-forming cells in the eye and draining lymph nodes. Ann Ophthalmol 1977, 9(11):1417-1421.
121. Zimmerman R.K. Staphylococcus aureus hordeolum as a cause of bacteremia and secondary foci. J Fam Pract 1989, 29(4):433-435.
122. Nalmas S., Bishburg E., Shah M., et al. Skin and soft tissue abscess: 1 year's experience. J Cutan Med Surg 2009, 13(5):257-261.
123. Schrock J.W., Laskey S., Cydulka R.K. Predicting observation unit treatment failures in patients with skin and soft tissue infections. Int J Emerg Med 2008, 1(2):85-90.
124. Stulberg D.L., Penrod M.A., Blatny R.A. Common bacterial skin infections. Am Fam Physician 2002, 66(1):119-124.
125. Napolitano L.M. Severe soft tissue infections. Infect Dis Clin North Am 2009, 23(3):571-591.
126. Teng C.S., Lo W.T., Wang S.R., et al. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. J Microbiol Immunol Infect 2009, 42(4):324-328.
127. Todd J.K. Staphylococcal toxin syndromes. Annu Rev Med 1985, 36:337-347.
128. Krasagakis K., Samonis G., Maniatakis P., et al. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology 2006, 212(1):31-35.
129. Gemmell C.G. Staphylococcal scalded skin syndrome. J Med Microbiol 1995, 43(5):318-327.
130. Amagai M., Matsuyoshi N., Wang Z.H., et al. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000, 6(11):1275-1277.
131. Nishifuji K., Sugai M., Amagai M. Staphylococcal exfoliative toxins: " molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008, 49(1):21-31.
132. Balaban N., Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol 2000, 61(1):1-10.
133. Le Loir Y., Baron F., Gautier M. Staphylococcus aureus and food poisoning. Genet Mol Res 2003, 2(1):63-76.
134. Thomas D., Chou S., Dauwalder O., et al. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 2007, 93:24-41.
135. Corpening A., Foxhall E.P. Outbreak of food poisoning, probably due to Staphylococcus aureus. Am J Public Health Nations Health 1935, 25(8):938-940.
136. Gilbert R.J., Wieneke A.A., Lanser J., et al. Serological detection of enterotoxin in foods implicated in staphylococcal food poisoning. J Hyg (Lond) 1972, 70(4):755-762.
137. Edmondson H.T., Rhode C.M., Seago R.W. Necrotizing fasciitis caused by hemolytic Staphylococcus aureus. Am Surg 1972, 38(9):523-526.
138. Todd J., Fishaut M., Kapral F., et al. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978, 2(8100):1116-1118.
139. Green J., Lynn W.A. Presentation and clinical features of severe sepsis. J R Coll Physicians Lond 2000, 34(5):418-423.
140. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001, 55:77-104.
141. Bradley S.F. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 2005, 26(6):643-649.
142. Fernandez Guerrero M.L., Gonzalez Lopez J.J., Goyenechea A., et al. Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 2009, 88(1):1-22.
143. Karadimas E.J., Bunger C., Lindblad B.E., et al. Spondylodiscitis. A retrospective study of 163 patients. Acta Orthop 2008, 79(5):650-659.
144. Gonzalez-Lopez J.J., Gorgolas M., Muniz J., et al. Spontaneous epidural abscess: analysis of 15 cases with emphasis on diagnostic and prognostic factors. Eur J Intern Med 2009, 20(5):514-517.
145. Mylona E., Samarkos M., Kakalou E., et al. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum 2009, 39(1):10-17.
146. Shirtliff M.E., Mader J.T. Acute septic arthritis. Clin Microbiol Rev 2002, 15(4):527-544.
147. Pintado V., Meseguer M.A., Fortun J., et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002, 21(12):864-868.
148. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009, 360(5):439-443.
149. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005, 40(4):562-573.
150. Menzies B.E. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 2003, 16(3):225-229.
151. Vercellotti G.M., Lussenhop D., Peterson P.K., et al. Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med 1984, 103(1):34-43.
152. Shuter J., Hatcher V.B., Lowy F.D. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996, 64(1):310-318.
153. Trivier D., Houdret N., Courcol R.J., et al. The binding of surface proteins from Staphylococcus aureus to human bronchial mucins. Eur Respir J 1997, 10(4):804-810.
154. Hoefnagels-Schuermans A., Peetermans W.E., Jorissen M., et al. Staphylococcus aureus adherence to nasal epithelial cells in a physiological in vitro model. In Vitro Cell Dev Biol Anim 1999, 35(8):472-480.
155. Holland D.B., Bojar R.A., Farrar M.D., et al. Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. FEMS Microbiol Lett 2009, 290(2):149-155.
156. DeLeo F.R., Diep B.A., Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 2009, 23(1):17-34.
157. Foster T.J. Immune evasion by staphylococci. Nat Rev Microbiol 2005, 3(12):948-958.
158. Larkin E.A., Carman R.J., Krakauer T., et al. Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr Med Chem 2009, 16(30):4003-4019.
159. Fowler T., Wann E.R., Joh D., et al. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol 2000, 79(10):672-679.
160. Sinha B., Fraunholz M. Staphylococcus aureus host cell invasion and post-invasion events. Int J Med Microbiol 2009, 300(2-3):170-175.
161. Kubica M., Guzik K., Koziel J., et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008, 3(1):e1409.
162. Anwar S., Prince L.R., Foster S.J., et al. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol 2009, 157(2):216-224.
163. Kerr A., Tan J.S. Biopsies of the Janeway lesion of infective endocarditis. J Cutan Pathol 1979, 6(2):124-129.
164. Narita S., Kaneko J., Chiba J., et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 2001, 268(1-2):195-206.
165. Deurenberg R.H., Vink C., Kalenic S., et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007, 13(3):222-235.
166. Ben Zakour N.L., Guinane C.M., Fitzgerald J.R. Pathogenomics of the staphylococci: insights into niche adaptation and the emergence of new virulent strains. FEMS Microbiol Lett 2008, 289(1):1-12.
167. Lindsay J.A. Genomic variation and evolution of Staphylococcus aureus. Int J Med Microbiol 2009, 300(2-3):98-103.
168. Novick R.P. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003, 49(2):93-105.
169. CLSI Performance standards for antimicrobial susceptibility testing 2009, 10th Informational Supplement, M100-S18, Clinical and Laboratory Standards Institute, Wayne (PA).
170. Peterson J.F., Riebe K.M., Hall G.S., et al. SpectraTM MRSA, a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2009, 48(1):215-219.
171. Diederen B., van Duijn I., van Belkum A., et al. Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43(4):1925-1927.
172. Flayhart D., Hindler J.F., Bruckner D.A., et al. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 2005, 43(11):5536-5540.
173. Fujita S., Senda Y., Iwagami T., et al. Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J Clin Microbiol 2005, 43(3):1149-1157.
174. Martineau F., Picard F.J., Ke D., et al. Development of a PCR assay for identification of staphylococci at genus and species levels. J Clin Microbiol 2001, 39(7):2541-2547.
175. Carroll K.C., Leonard R.B., Newcomb-Gayman P.L., et al. Rapid detection of the staphylococcal mecA gene from BACTEC blood culture bottles by the polymerase chain reaction. Am J Clin Pathol 1996, 106(5):600-605.
176. Chapin K., Musgnug M. Evaluation of three rapid methods for the direct identification of Staphylococcus aureus from positive blood cultures. J Clin Microbiol 2003, 41(9):4324-4327.
177. Oliveira K., Procop G.W., Wilson D., et al. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 2002, 40(1):247-251.
178. Paule S.M., Pasquariello A.C., Thomson R.B., et al. Real-time PCR can rapidly detect methicillin-susceptible and methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles. Am J Clin Pathol 2005, 124(3):404-407.
179. Goldmeyer J., Li H., McCormac M., et al. Identification of Staphylococcus aureus and determination of methicillin resistance directly from positive blood cultures by isothermal amplification and a disposable detection device. J Clin Microbiol 2008, 46(4):1534-1536.
180. Johnson G., Millar M.R., Matthews S., et al. Evaluation of BacLite Rapid MRSA, a rapid culture based screening test for the detection of ciprofloxacin and methicillin resistant S. aureus (MRSA) from screening swabs. BMC Microbiol 2006, 6:83.
181. Boyce J.M., Havill N.L. Comparison of BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR versus the CHROMagar MRSA assay for screening patients for the presence of MRSA strains. J Clin Microbiol 2008, 46(1):350-351.
182. Paule S.M., Hacek D.M., Kufner B., et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 2007, 45(9):2993-2998.
183. Rossney A.S., Herra C.M., Brennan G.I., et al. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens. J Clin Microbiol 2008, 46(10):3285-3290.
184. Wolk D.M., Picton E., Johnson D., et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009, 47(3):758-764.
185. Podzorski R.P., Li H., Han J., et al. MVPlex assay for direct detection of methicillin-resistant Staphylococcus aureus in naris and other swab specimens. J Clin Microbiol 2008, 46(9):3107-3109.
186. Tacconelli E., De Angelis G., de Waure C., et al. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009, 9(9):546-554.
187. Shopsin B., Kreiswirth B.N. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001, 7(2):323-326.
188. Struelens M.J., Hawkey P.M., French G.L., et al. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect 2009, 15(2):112-119.
189. Prevost G., Pottecher B., Dahlet M., et al. Pulsed field gel electrophoresis as a new epidemiological tool for monitoring methicillin-resistant Staphylococcus aureus in an intensive care unit. J Hosp Infect 1991, 17(4):255-269.
190. Tang Y.W., Waddington M.G., Smith D.H., et al. Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2000, 38(4):1347-1351.
191. Tenover F.C., Gay E.A., Frye S., et al. Comparison of typing results obtained for methicillin-resistant Staphylococcus aureus isolates with the DiversiLab system and pulsed-field gel electrophoresis. J Clin Microbiol 2009, 47(8):2452-2457.
192. Enright M.C., Day N.P., Davies C.E., et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38(3):1008-1015.
193. Maiden M.C., Bygraves J.A., Feil E., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998, 95(6):3140-3145.
194. Frenay H.M., Bunschoten A.E., Schouls L.M., et al. Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996, 15(1):60-64.
195. Stephens A.J., Inman-Bamber J., Giffard P.M., et al. High-resolution melting analysis of the spa repeat region of Staphylococcus aureus. Clin Chem 2008, 54(2):432-436.
196. Moser S.A., Box M.J., Patel M., et al. Multiple-locus variable-number tandem-repeat analysis of meticillin-resistant Staphylococcus aureus discriminates within USA pulsed-field gel electrophoresis types. J Hosp Infect 2009, 71(4):333-339.
197. Sabat A., Krzyszton-Russjan J., Strzalka W., et al. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol 2003, 41(4):1801-1804.
198. Deplano A., Schuermans A., Van Eldere J., et al. Multicenter evaluation of epidemiological typing of methicillin-resistant Staphylococcus aureus strains by repetitive-element PCR analysis. J Clin Microbiol 2000, 38(10):3527-3533.
199. Ross T.L., Merz W.G., Farkosh M., et al. Comparison of an automated repetitive sequence-based PCR microbial typing system to pulsed-field gel electrophoresis for analysis of outbreaks of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43(11):5642-5647.
200. Hall T.A., Sampath R., Blyn L.B., et al. Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization-mass spectrometry. J Clin Microbiol 2009, 47(6):1733-1741.
201. Wolk D.M., Blyn L.B., Hall T.A., et al. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype. J Clin Microbiol 2009, 47(10):3129-3137.
202. White E.J., Fridrikh S.V., Chennagiri N., et al. Staphylococcus aureus strain typing by single-molecule DNA mapping in fluidic microships with fluorescent tags. Clin Chem 2009, 55(12):2121-2129.
203. Tang Y.W. Progress toward rapid and accurate Staphylococcus aureus strain typing. Clin Chem 2009, 55(12):2074-2076.
204. Hyun D.Y., Mason E.O., Forbes A., et al. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2009, 28(1):57-59.
205. Ramirez-Schrempp D., Dorfman D.H., Baker W.E., et al. Ultrasound soft-tissue applications in the pediatric emergency department: to drain or not to drain?. Pediatr Emerg Care 2009, 25(1):44-48.
206. Miles F., Voss L., Segedin E., et al. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Arch Dis Child 2005, 90(12):1274-1278.
207. Verhagen D.W., van der Meer J.T., Hamming T., et al. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis 2003, 35(8):459-463.
208. Jenkins T.C., Price C.S., Sabel A.L., et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46(7):1000-1008.
209. Lahey T., Shah R., Gittzus J., et al. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore) 2009, 88(5):263-267.
210. Takei S., Arora Y.K., Walker S.M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993, 91(2):602-607. [comment].
211. Yanagisawa C., Hanaki H., Natae T., et al. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. J Infect Chemother 2007, 13(6):368-372.
212. Gauduchon V., Cozon G., Vandenesch F., et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 2004, 189(2):346-353.
213. Powell J.P., Wenzel R.P. Antibiotic options for treating community-acquired MRSA. Expert Rev Anti Infect Ther 2008, 6(3):299-307.
214. Schlievert P.M. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001, 108(Suppl 4):S107-S110.
215. Schaffer A.C., Lee J.C. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 2009, 23(1):153-171.
216. Espersen F., Hedstrom S.A. Recurrent staphylococcal furunculosis: antibody response against Staphylococcus aureus. Scand J Infect Dis 1984, 16(4):413-414.
217. Tsuda S. Immunological aspects of staphylococcal skin infection. J Dermatol 1977, 4(4):123-128.
218. El-Gilany A.H., Fathy H. Risk factors of recurrent furunculosis. Dermatol Online J 2009, 15(1):16.
219. Shinefield H.R. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?. Vaccine 2006, 24(Suppl 2). S2-65-9.
220. O'Riordan K., Lee J.C. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004, 17(1):218-234.
221. Foster T.J. Potential for vaccination against infections caused by Staphylococcus aureus. Vaccine 1991, 9(4):221-227.
222. Middleton J.R. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines 2008, 7(6):805-815.
223. Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 1999, 20(2):163-173.